Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the trial is to determine if survival to hospital discharge is
improved with early therapeutic administration of a new Captisol-Enabled formulation of IV
amiodarone (Nexterone-PM101) compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
University of Washington
Collaborators:
American Heart Association Canadian Institutes of Health Research (CIHR) Defence Research and Development Canada Heart and Stroke Foundation of Canada National Heart, Lung, and Blood Institute (NHLBI) U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command